Overview
DBD market data
Price History
DBD price chart
Valuation & Profitability
- P/E (TTM)
- 22.05 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $2.54 Diluted earnings per share over the trailing twelve months.
- Beta
- -52.04 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 2.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $54.48 – $92.09 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $2.5B · P/B 2.21 · P/S 0.63.
Company News
Diebold Nixdorf shares are trading lower. The company reported its Q2 financial results.Benzinga · Jul 29, 2026, 2:45 PM
Diebold Nixdorf Affirms FY2026 Adj EPS Guidance of $5.25-$5.75 vs $5.49 Est; Affirms FY2026 Sales Guidance of $3.860B-$3.940B vs $3.912B EstBenzinga · Jul 29, 2026, 11:10 AM
8-K filing — DIEBOLD NIXDORF, Inc (DBD)SEC EDGAR · Jul 29, 2026, 11:06 AM
Diebold Nixdorf Q2 Adj. EPS $1.10, Inline, Sales $930.800M Beat $926.368M EstimateBenzinga · Jul 29, 2026, 11:02 AM